Reply To: Avacta

Nick Hargrave

Q&A from the December shareholder presentation published. Obviously there is a need to read between some lines but this once again highlights the potential value of the platform that remains seemingly well hidden from the market. Commercial deals licensing the Pre-Cision platform to generate non-dilutive funding to advance its own lead assets are the catalyst the market likely needs to take notice